Cancer statistics in Europe are stark: according to the World Health Organisation (WHO), the disease causes 20 % of deaths in the European Region. With more than 3 million new cases and 1.7 million deaths each year, cancer is the most important cause of death and morbidity in Europe after cardiovascular diseases.
 
However, most of us don’t have to look to the statistics to be 
convinced. The majority of Europeans have been touched by cancer in some
 way, whether through friends, family or personal experience. We know 
that cancer enters lives indiscriminately and can have devastating 
effects. What we also now know that cancer is in many cases avoidable, 
and early detection increases the chance of cure substantially.
In fact, WHO says that enough is already known about the causes to 
prevent at least one third of all cancers, and some of the most common 
types – including breast, colorectal and cervical cancer – can be cured 
if detected early.
This knowledge has come about through intense research efforts which
 have also led to the development of successful anti-cancer therapies 
and treatments. Horizon 2020 is supporting emerging endeavours in this 
area under the challenge of 
Health, Demographic Change and Wellbeing.
 Among other things, research and innovation supported by this call aims
 to improve our understanding of the causes and mechanisms underlying 
disease; and improve our ability to monitor health and to prevent, 
detect, treat and manage disease.
Not only will research efforts feed into improving detection and 
treatment, they will also help influence policy. The EU’s 
recently-established Expert Group on Cancer Control intends to use this 
kind of research when assisting the Commission in the drawing up of 
legal instruments and policy documents, guidelines and recommendations 
on cancer control.